Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
US Department of Justice
Julphar
Dow
Merck
Fish and Richardson
Mallinckrodt
Moodys
Cipla

Generated: February 20, 2019

DrugPatentWatch Database Preview

Drug Price Trends for NEOMYC-BACIT-POLYMIX EYE OINT

« Back to Dashboard

Drug Price Trends for NEOMYC-BACIT-POLYMIX EYE OINT

Average Pharmacy Cost for NEOMYC-BACIT-POLYMIX EYE OINT

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
NEOMYC-BACIT-POLYMIX EYE OINT 24208-0780-55 7.93381 GM 2019-01-23
NEOMYC-BACIT-POLYMIX EYE OINT 57237-0129-53 7.93381 GM 2019-01-23
NEOMYC-BACIT-POLYMIX EYE OINT 57237-0129-53 7.42476 GM 2018-12-19
Drug Name NDC Price/Unit ($) Unit Date

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Cipla
Julphar
Accenture
Express Scripts
Deloitte
Colorcon
McKesson
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.